Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 1.19 | N/A |
| PEG Ratio (TTM) | -0.21 | N/A |
| P/S Ratio (TTM) | 0.04 | N/A |
| P/B Ratio (TTM) | 0.01 | N/A |
| P/FCF Ratio (TTM) | -0.05 | N/A |
| Price to 5YR AVG Earnings Ratio | 0.76 | N/A |
| Price to 5YR AVG FCF Ratio | -0.23 | N/A |
Profitability (18%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.93% | N/A |
| ROE (TTM) | 0.98% | N/A |
| Net Profit Margin (TTM) | 1.85% | N/A |
| ROIC 5YR AVG | 1.98% | N/A |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 44.46% | 40.17% | 133.87% |
| Revenue | -0.76% | 10.49% | 39.05% |
| Net Income | 115.38% | 147.17% | 90.04% |
| Cash Flow | -112.20% | -56.20% | 331.17% |
Health (56%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 21.81 | N/A |
| Quick Ratio (TTM) | 3.45 | N/A |
| D/E Ratio (TTM) | 0.04 | N/A |
| Interest Coverage (TTM) | 1.22 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 2.82 | N/A |
| LTL to 5YR AVG FCF | -0.15 | N/A |
| Shares Outstanding Growth 5YR AVG | 189.90% | N/A |